Table 4.
CT lung involvement in survivors (group A) and non-survivors (group B) at admission.
| Parameter | Group A Median [Q1, Q3] |
Group B Median [Q1, Q3] |
p-Value |
|---|---|---|---|
| alveolar lesions (%) | 1.8 [1; 3.2] | 3.1 [1.5; 5.1] | 0.062 |
| mixt lesions (%) | 4.6 [2.5; 7.3] | 6.9 [4.1; 12] | 0.036 |
| interstitial lesions (%) | 39.4 [31.7; 47.8] | 49.2 [44.3; 60.1] | 0.001 |
| total lung involvement (%) | 47.2 [35.9; 63] | 64.9 [48.1; 74.1] | 0.003 |
| normal lung densities (%) | 52.7 [37; 64.1] | 35.1 [25.9;51.9] | 0.003 |
| Cluster 1 (2–10 mmc) (%) | 0.4 [0.2; 0.9] | 1.1 [0.3; 1.5] | 0.029 |
| Cluster 2 (10–60 mmc) (%) | 0.45 [0.2; 0.9] | 0.9 [0.3; 1.7] | 0.011 |
| Cluster 3 (60–200 mmc) (%) | 0.1 [0; 0.3] | 0.4 [0.2; 0.6] | 0.001 |
| Cluster 4 (over 200 mmc) (%) | 51.6 [35.5; 63.7] | 33 [20.7; 51.7] | 0.002 |
| lobes with interstitial lesions (n) | 5 [5; 5] | 5 [5; 5] | 0.931 |
| lobes with alveolar lesions (n) | 0 [1; 2] | 0 [0; 2] | 0.306 |
| lobes with atelectatic changes (n) | 3.5 [2; 5] | 2 [2; 4] | 0.253 |